[
  {
    "ts": null,
    "headline": "Incyte Corp. stock underperforms Thursday when compared to competitors",
    "summary": "Incyte Corp. stock underperforms Thursday when compared to competitors",
    "url": "https://finnhub.io/api/news?id=b3df816d278bda66be6d104965297de56fe73ae7293af7188a6b18147cb10ca2",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1732209300,
      "headline": "Incyte Corp. stock underperforms Thursday when compared to competitors",
      "id": 131615118,
      "image": "",
      "related": "INCY",
      "source": "MarketWatch",
      "summary": "Incyte Corp. stock underperforms Thursday when compared to competitors",
      "url": "https://finnhub.io/api/news?id=b3df816d278bda66be6d104965297de56fe73ae7293af7188a6b18147cb10ca2"
    }
  },
  {
    "ts": null,
    "headline": "Biotech Stock Roundup: SAGE, INCY Suffer Setbacks, JAZZ Wins Oncology Drug Approval & More",
    "summary": "SAGE and INCY suffer setbacks due to the failure of HD and CSU studies, respectively.",
    "url": "https://finnhub.io/api/news?id=0e2462c9b6db076f0d5152b4a4d573fdb225c54dce2a45e37aad82e7ba826330",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1732209180,
      "headline": "Biotech Stock Roundup: SAGE, INCY Suffer Setbacks, JAZZ Wins Oncology Drug Approval & More",
      "id": 131547416,
      "image": "",
      "related": "INCY",
      "source": "Yahoo",
      "summary": "SAGE and INCY suffer setbacks due to the failure of HD and CSU studies, respectively.",
      "url": "https://finnhub.io/api/news?id=0e2462c9b6db076f0d5152b4a4d573fdb225c54dce2a45e37aad82e7ba826330"
    }
  }
]